Abstract
Cardiovascular disease is a leading cause of morbidity and mortality in the United States, resulting in an estimated $503 billion in indirect and direct costs in 2010. Annually, there are 1.8 million hospitalizations for acute coronary syndromes. The total number of inpatient cardiovascular operations and procedures increased 27 %, from 1997 to 2007 in the Unites States (National Heart, Lung, and Blood Institute computation based on National Center for Health Statistics annual data). About 10–16 % of patients with coronary artery disease go on to have coronary artery bypass graft surgery (CABG), and each year approximately one million patients worldwide undergo cardiac surgery such as CABG, valve repair or replacement, aneurysm repairs, and arrhythmia surgery. Data for 2008 from the Society of Thoracic Surgeons show that most of these patients require at least an overnight ICU stay, with a mean of about 4 days. Management of cardiovascular surgery patients is complex, encompassing numerous different areas including infectious disease, cardiology, diabetes, and critical care. This chapter reviews the common pharmacologic agents employed by providers in the ICU setting.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American Psychiatric Association: practice guideline for the treatment of patients with delirium (1999) Am J Psychiatry 156(5 suppl):1–20
American Society of Health-System Pharmacists (1999) ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 56(18):1839–1888
ASHP therapeutic guidelines on stress ulcer prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998 (1999) Am J Health Syst Pharm 56(4):347
Bratzler DW, Houck PM (2004) Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38:1706–1715
Bruno JJ, Warren ML (2010) Intensive care delirium. Crit Care Nurs Clin North Am 22:161–178
Cooper BE (2008) Review and update on inotropes and vasopressors. AACN Adv Crit Care 19(1):5–15
Dipiro JT, Talbert RL, Yee GC et al (2002) Pharmacotherapy: a pathophysiologic approach, 5th edn. McGraw-Hill Co. Inc., New York
Edwards FH et al (2006) The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, part I: duration. Ann Thorac Surg 81:397–404
Engelman R et al (2007) The Society of Thoracic Surgeons practice guideline series: antibiotic prophylaxis in cardiac surgery, Part II: Antibiotic choice. Ann Thorac Surg 83:1569–1576
Falciglia M et al (2009) Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 37(12):3001
Ganjehei L, Massumi A, Nazeri A, Razavi M (2011) Pharmacologic management of arrhythmias. Tex Heart Inst J 38(4):344–349
Griesdale DE et al (2009) Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-Sugar study data. CMAJ 180:821
Grube RR, May DB (2007) Stress ulcer prophylaxis in hospitalized patients not in intensive care units. Am J Health Syst Pharm 64:1396–1400
Havel C, Arrich J, Losert H, Gamper G, Müllner M, Herkner H (2011). Vasopressors for hypotensive shock. Cochrane Database Syst Rev (5):Art. No. CD003709. doi:10.1002/14651858.CD003709.pub3
http://www.ashp.org/DocLibrary/Policy/PatientSafety/Optimizing-Med-Reconciliation.aspx
http://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm050792.htm
http://www.forbes.com/sites/dougschoen/2012/02/13/the-drug-shortage-crisis-in-america/
icudelirium.org. Available at: http://icudelirium.org/index.html
Jacobi J et al (2002) Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Crit Care Med 30(1):119
Kee VR (2003) Hemodynamic pharmacology of intravenous vasopressors. Crit Care Nurse 23:79–82
Koda-Kimble MA (2006) Applied therapeutics: the clinical use of drugs, 8th edn. Lippincott Williams & Wilkins, Philadelphia
Kowey P (1998) Pharmacologic effects of antiarrhythmic drugs. Arch Intern Med 158(4):325–332
Micromedex® 2.0 2012. Accessed August 2012
Murray M et al (2002) Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists (ASHP), American College of Chest Physicians. Crit Care Med 30:142–156
Ostermann ME, Keenan SP, Seiferling RA, Sibbald WJ (2000) Sedation in the intensive care unit: a systematic review. JAMA 283(11):1451–1459
Overgaard CB, Davík V (2008) Contemporary reviews in cardiovascular medicine: inotropes and vasopressors. Circulation 118:1047–1056
Poor K, Stanke S (2005) Understanding adult hemodynamics: a primer for cardiovascular surgery and hemodynamic monitoring. TCHP Education Consortium
Rhoney D, Peacock W (2009) Intravenous therapy for hypertensive emergencies, part 1. Am J Health Syst Pharm 66:1343–1352
Sessler CN (2005) Sedation, analgesia and neuromuscular blockade for high-frequency oscillatory ventilation. Crit Care Med 33(Suppl):S209–S216
Spirt MJ, Stanley S (2006) Update on stress ulcer prophylaxis in critically ill patients. Crit Care Nurse 26(1):18
Standards of Medical Care in Diabetes – 2012. Diabetes Care 35:S11–S63
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VII). (2003) JAMA 289(19):2560–2572
Therapeutic guidelines on antimicrobial prophylaxis in surgery section: executive summary (Draft) 2012
Thireau J et al (2011) New drugs vs. old concepts: a fresh look at antiarrhythmics. Pharmacol Ther 132(2):125–145
Thoratec Infection control guidelines for the Heartmate® XVE Left Ventricular Assist System. Available at http://www.transmedic.com.tw/doc/Infection%20Control%20Guidelines-RevB.pdf
Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA (2001) Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 29(3):487–493
Van den Berghe G et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359
Vender JS, Szokol JW, Murphy GS et al (2004) Sedation, analgesia, and neuromuscular blockade in sepsis: an evidenced-based review. Crit Care Med 32(suppl):S554–S561
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fellin, R. (2014). Cardiovascular Pharmacology. In: Dabbagh, A., Esmailian, F., Aranki, S. (eds) Postoperative Critical Care for Cardiac Surgical Patients. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40418-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-40418-4_2
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40417-7
Online ISBN: 978-3-642-40418-4
eBook Packages: MedicineMedicine (R0)